يعرض 1 - 10 نتائج من 137 نتيجة بحث عن '"Blood Coagulation/drug effects"', وقت الاستعلام: 1.13s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    المساهمون: UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (MGD) Laboratoire de biologie clinique, Biochemie, RS: CARIM - R1.01 - Blood proteins & engineering, Promovendi CD, RS: CARIM - R1.04 - Clinical thrombosis and haemostasis

    المصدر: Thrombosis research, Vol. 171, p. 160-166 (2018)
    Thrombosis Research, 171, 160-166. Elsevier Science

  6. 6

    المساهمون: University of Zurich

    المصدر: Barco, Stefano; Bingisser, Roland; Colucci, Giuseppe; Frenk, André; Gerber, Bernhard; Held, Ulrike; Mach, Francois; Mazzolai, Lucia; Righini, Marc; Rosemann, Thomas; Sebastian, Tim; Spescha, Rebecca; Stortecky, Stefan; Windecker, Stephan; Kucher, Nils (2020). Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial. Trials, 21(1), p. 770. BioMed Central 10.1186/s13063-020-04678-4 <http://dx.doi.org/10.1186/s13063-020-04678-4>
    Trials, vol. 21, no. 1, pp. 770
    Trials, Vol 21, Iss 1, Pp 1-3 (2020)
    Trials

    مصطلحات موضوعية: 11035 Institute of General Practice, medicine.medical_specialty, Acute coronary syndrome, Letter, Randomization, venous thromboembolism, Medicine (miscellaneous), 610 Medicine & health, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Betacoronavirus/pathogenicity, Blood Coagulation/drug effects, Coronavirus Infections/blood, Coronavirus Infections/diagnosis, Coronavirus Infections/drug therapy, Coronavirus Infections/virology, Enoxaparin/administration & dosage, Enoxaparin/adverse effects, Equivalence Trials as Topic, Host-Pathogen Interactions, Humans, Multicenter Studies as Topic, Pandemics, Pneumonia, Viral/blood, Pneumonia, Viral/diagnosis, Pneumonia, Viral/drug therapy, Pneumonia, Viral/virology, Thrombosis/blood, Thrombosis/diagnosis, Thrombosis/prevention & control, Thrombosis/virology, Time Factors, Treatment Outcome, COVID-19, Randomised controlled trial, anticoagulation, elderly, enoxaparin, prevention, protocol, thrombosis, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, Informed consent, law, medicine, Sore throat, Pharmacology (medical), 030212 general & internal medicine, Stroke, COVID, lcsh:R5-920, business.industry, 10031 Clinic for Angiology, 10060 Epidemiology, Biostatistics and Prevention Institute (EBPI), medicine.disease, Comorbidity, Emergency medicine, Ambulatory, medicine.symptom, lcsh:Medicine (General), business, 030217 neurology & neurosurgery

    وصف الملف: application/pdf

  7. 7

    المصدر: Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, vol 20, iss 11
    Pediatric Critical Care Medicine, Vol. 20, No 11 (2019) pp. 1034-1039
    Pediatr Crit Care Med

    وصف الملف: application/pdf

  8. 8

    المصدر: Mannheimer, B, Stage, T B, Pottegård, A & Lindh, J D 2019, ' The Effect of Flucloxacillin on Warfarin Anticoagulation : A Swedish Register-Based Nationwide Cohort Study ', Thrombosis and Haemostasis, vol. 119, no. 10, pp. 1617-1623 . https://doi.org/10.1055/s-0039-1693462

  9. 9
  10. 10
    رسالة جامعية